Manufacturer financial conflicts of interest are associated with favourable outcomes in randomised controlled trials of liposomal bupivacaine

Br J Anaesth. 2022 Oct;129(4):e90-e93. doi: 10.1016/j.bja.2022.06.032. Epub 2022 Aug 16.

Affiliations

¹ Integrated Anesthesia Associates, LLC, Hartford Hospital, Hartford, CT, USA. Electronic address: kevin.finkel@hhchealth.org.
² Integrated Anesthesia Associates, LLC, Hartford Hospital, Hartford, CT, USA.
³ University of Connecticut School of Medicine, Farmington, CT, USA.
⁴ Frank H. Netter School of Medicine, Quinnipiac University, North Haven, CT, USA.
⁵ George Washington University, Washington, DC, USA.

PMID: 35981918
DOI: 10.1016/j.bja.2022.06.032

No abstract available

Keywords: EXPAREL; analgesia; bupivacaine; conflict of interest; financial disclosure; liposomal bupivacaine; regional anaesthesia.

Publication types

Letter

MeSH terms

Anesthetics, Local
Bupivacaine*
Conflict of Interest*
Humans
Pain, Postoperative
Randomized Controlled Trials as Topic

Substances

Anesthetics, Local
Bupivacaine